Pulmonary embolism, or PE, is a deadly condition causing blood clots within a patient’s lungs that has grown in prevalence during the COVID-19 pandemic. The Indigo Aspiration System with Lightning 12 ...

LOS ANGELES--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced results of the company-sponsored PROMISE Study, demonstrating ...

Results of EXTRACT-PE Trial presented at Vascular InterVentional Advances (VIVA) Annual Meeting “The Indigo Aspiration System has demonstrated tremendous potential to address patients with clot in ...

The FDA has announced 510(k) clearance for expanded indication of the latest iteration of Penumbra's (NYSE:PEN +1.3%) Indigo Aspiration System, Lightning 12. As part of the Indigo Aspiration System, ...

The Penumbra 3D Trial successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy of the company's next-generation stent retriever, Penumbra 3D ...

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced that its Indigo Aspiration System with Lightning 7 and Lightning 12 have secured CE Mark (Conformité ...

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, and Asahi Intecc Co., a leading Japanese medical device manufacturer, announced that they will collaborate to ...

ALAMEDA, Calif. – Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced enrollment of the first patient into the CHEETAH study, a prospective, multi-center U.S.

Please provide your email address to receive an email when new articles are posted on . Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded ...

Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System's most advanced technology: Penumbra JET 7 and Penumbra ...

February 28, 2008 (New Orleans, Louisiana) -- Results of a prospective, single-cohort, phase 2 study show safety and effectiveness for recanalization of the Penumbra System aspiration catheter in ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for ...